Psychiatry AtlasMedication guide · United States

Sleep medicine

Zolpidem (Ambien, Ambien CR)

Generic name
zolpidem tartrate
Brand names
Ambien; Ambien CR
Medication class
Sleep medicine
Forms covered
Ambien immediate-release tablets; Ambien CR extended-release tablets

Article updated: 2026-10-30 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

FDA Boxed Warning

Ambien immediate-release tablets; Ambien CR extended-release tablets.

Zolpidem can cause sleepwalking, sleep-driving or other activities while not fully awake, sometimes resulting in serious injury or death. Stop zolpidem immediately and contact the prescriber if a complex sleep behavior occurs.

Zolpidem (Ambien) helps adults fall asleep; Ambien CR is an extended-release product for falling and staying asleep. Both have a boxed warning for potentially dangerous activities performed while not fully awake.

What to expect: The intended sleep effect occurs on nights the medicine is taken, but next-morning impairment can remain even when you feel awake.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Short-term insomnia with difficulty initiating sleep — Adults. Pediatric efficacy is not established.Ambien immediate-release tablets.
  • Short-term insomnia with sleep-onset and/or sleep-maintenance difficulty — Adults. Different release form and dose.Ambien CR extended-release tablets.

What should I expect?

The intended sleep effect occurs on nights the medicine is taken, but next-morning impairment can remain even when you feel awake. Ambien and Ambien CR have different release patterns and uses.

If insomnia persists after 7–10 days or worsens, contact the prescriber to reassess its cause. Treatment should be as short as possible, with continued use reviewed rather than automatically renewed.

How do I take it safely?

Take only once, immediately before bed, with 7–8 hours before planned awakening. Food can delay the effect. Swallow CR tablets whole; never split, crush or chew them.

Use the exact prescribed formulation and dose. Sex, age and liver function affect the labeled starting dose. Avoid severe liver impairment use. Do not combine Ambien, Ambien CR or another zolpidem product.

Avoid alcohol and unreviewed opioids, benzodiazepines or sleep medicines. Review antifungals, rifampin, St. John’s wort and other interacting drugs. Ambien CR users are cautioned against driving the day after use.

Do not use after prior zolpidem-related complex sleep behavior or allergy. Report sleep apnea, other breathing disease, myasthenia gravis, depression, suicidal thoughts, falls or substance-use history.

Skip a missed bedtime dose if a full 7–8 hours are unavailable. Never redose the same night, double or take a daytime catch-up dose. After regular use, discuss gradual stopping because abrupt reduction can cause withdrawal.

Discuss pregnancy and breastfeeding. Late exposure can suppress newborn breathing; milk exposure can cause infant sedation. The label describes expressing and discarding milk through 23 hours after a dose as an exposure-reduction option. Pediatric use is not established.

What side effects should I know about?

  • Sleepiness, dizziness, headache, diarrhea and memory or coordination difficulties, depending on product and study.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • FDA boxed warning: complex sleep behaviors, including sleepwalking, sleep-driving and other activities while not fully awake, can cause serious injury or death. They can occur after the first or a later dose, even at recommended doses and without alcohol. Stop the medicine immediately and contact the prescriber if this occurs.
  • New suicidal thoughts or a severe mood or behavior change needs immediate clinical contact; get emergency help if someone cannot stay safe.
  • Severe confusion or unusual behavior needs prompt assessment. Rapid stopping after regular use can cause withdrawal, including seizures.
  • Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.
  • Ambien and Ambien CR are not recommended for children under 18. Pediatric safety and effectiveness are not established; an ADHD-associated insomnia study did not show improved sleep onset and reported hallucinations and other adverse reactions.

What else should I know to stay safe?

  • Do not use after zolpidem-related complex sleep behavior or allergy. Severe liver impairment should be avoided. Review sleep apnea, other breathing disease, myasthenia gravis, depression, falls and substance-use history; sex, age and liver function affect the appropriate dose.
  • Avoid alcohol and unreviewed opioids, sedatives or sleep medicines, including another zolpidem product. Have other interactions checked. Ambien CR users are cautioned against driving the next day. Regular use may need an individual gradual stopping plan.
  • Discuss pregnancy and breastfeeding. Late exposure may suppress newborn breathing; milk exposure can sedate infants. The label describes expressing and discarding milk through 23 hours after a dose as an exposure-reduction option. Pediatric use is not established.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • A full night in bed does not guarantee unimpaired driving. Ambien CR specifically cautions against driving the next day.
  • Women and older adults often need lower starting doses because the medicine can remain at higher levels the next morning.
  • Sleepwalking or sleep-driving is not just an ordinary side effect to tolerate: stop the medicine and contact the prescriber immediately.

How does it work?

Zolpidem strengthens the response to GABA, a chemical messenger that reduces activity in many brain cells. This can help bring on sleep, while also affecting memory, coordination and alertness. The same medicine can continue to affect those functions after a person has woken.

Explore more in Brain & Science: Benzodiazepines and GABA: Alprazolam.

How was this medicine developed?

Ambien received FDA approval in 1992 and Ambien CR in 2005. Later safety changes emphasized next-morning impairment and complex sleep behaviors, showing why older dosing advice may no longer reflect current precautions.

How do I say the name?

Zolpidem: ZOL-pi-dem. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Ambien: current prescribing information
  2. Ambien CR: prescribing information
  3. Ambien: FDA approval history
  4. Zolpidem: patient medicine information
  5. Ambien CR: FDA approval history
  6. Ambien: Package Insert / Prescribing Information / MOA
  7. Ambien: FDA prescribing information
  8. Ambien CR: FDA prescribing information
  9. Lunesta: current prescribing information
  10. Zolpidem: verified neutral parent, PubChem CID 5732
  11. ISMP List of Confused Drug Names
  12. Frequently Asked Questions about Labeling for Prescription Medicines | FDA
  13. Schizophrenia
  14. NIMH: Understanding psychosis

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top